SGO Communique: Considerations When Treating Cervical, Vulvar, and Vaginal Cancers in the Setting of Cisplatin and Carboplatin Shortages
May 02, 2023
May 02, 2023
CHICAGO, Illinois, May 2 (TNSres) -- The Society of Gynecologic Oncology issued the following news release:
A platinum drug shortage in the US was first reported to the FDA on February 10th, 2023. Please refer to the SGO Rapid Communique dated April 21st, 2023 for details and guidance regarding platinum dosing and sparing strategies. This communication provides guidance for treating patients with cervical, vulvar, or vaginal cancers in the context of limited drug availability.
. . .
A platinum drug shortage in the US was first reported to the FDA on February 10th, 2023. Please refer to the SGO Rapid Communique dated April 21st, 2023 for details and guidance regarding platinum dosing and sparing strategies. This communication provides guidance for treating patients with cervical, vulvar, or vaginal cancers in the context of limited drug availability.
. . .